Vifor (International) AG

St. Gallen, SG

UEI
R77QQUHCTUP7
CAGE
SDVD5
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
International Organization
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
Rechenstrasse 37, 9014 St. Gallen, Switzerland
Website
viforpharma.com
Founded
1927
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Vifor (International) AG's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Korsuva (difelikefalin) Contract · 36C25226N0475 Veterans Integrated Service Network 12 $3,546
Mircera 120MCG/0.3ML syringe Contract · 36C26126N0435 Veterans Integrated Service Network 21 $2,730
Emergency pharmaceutical - mircera 120MCG/0.3ML Contract · 36C26126N0323 Veterans Integrated Service Network 21 $114
Mircera NDC 59353-0401-09 0.3ML FSS contract 36F79720D0075 methoxy polyethylene glycol-epoetin beta 50MCG/0.3ML… Contract · 36C26126F0065 Veterans Integrated Service Network 21 $160
Korsuva 50 MG Contract · 36C24525N0404 Veterans Integrated Service Network 5 $1,366

About Vifor (International) AG

Vifor (International) AG, a Swiss-based foreign-owned pharmaceutical manufacturer, supplies specialized anemia, nephrology, and pruritus treatments to the Department of Veterans Affairs as a prime contractor exclusively through the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and related blanket purchase agreements. The company competes on full-and-open awards without set-asides; all 22 prime awards in the recent footprint are unrestricted competition.

Vifor's federal capability portfolio centers on four core pharmaceutical products for veteran healthcare. MIRCERA (methoxy polyethylene glycol-epoetin beta), an anemia treatment, anchors the largest contract vehicle — a $23.8 million blanket purchase agreement with the VA National Acquisition Center running through June 2026. KORSUVA (difelikefalin), a pruritus treatment, is covered under a $150,000 single-award BPA also held through June 2026. KRYSTEXXA (pegloticase) for gout treatment and related pharmaceutical formulations round out the active supply set. Recent delivery-order work includes a $2,730 order from Veterans Integrated Service Network 21 for MIRCERA 120 MCG syringes (April 2026), a $11,310 KORSUVA delivery order from VISN 20 (April 2024), and a $3,678 KRYSTEXXA 8 MG order from VISN 5 (May 2024). Vifor also holds a new $750,000 Federal Supply Schedule contract awarded by VISN 12 effective May 1, 2026, through April 30, 2031, covering the same pharmaceutical product line.

Customer concentration is absolute — 100% of awards fund VA programs across five distinct Veterans Integrated Service Networks. The VA National Acquisition Center holds the two largest vehicles by potential value ($24 million combined), while VISN 12, VISN 21, VISN 5, and VISN 20 place individual small-dollar delivery orders. The distinction between the two rankings is stark: the National Acquisition Center's two blanket purchase agreements dwarf the 20 delivery orders issued by field VISNs, which individually range from $65 to $11,310. Activity accelerated sharply in 2024 (12 awards) after minimal prior volume (2 awards in 2020, 1 in 2023), with 3 awards in 2025 and 3 in 2026. Only one award ($3,000 in combined potential value) reaches completion within the next twenty-four months, indicating stable recompete exposure through 2026 for the two major BPAs. Vifor operates as a pure prime contractor with no subcontract footprint in the federal government. Place of performance spans multiple VA facilities nationwide with administrative coordination through the Pharmaceuticals and Drugs FSS-61-IB schedule.

Contract vehicles

Quick answers

What is Vifor (International) AG's UEI?

Vifor (International) AG's Unique Entity ID (UEI) in SAM.gov is R77QQUHCTUP7.

What is Vifor (International) AG's CAGE code?

Vifor (International) AG's CAGE code is SDVD5.

What is Vifor (International) AG's primary NAICS code?

Vifor (International) AG's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Vifor (International) AG located?

Vifor (International) AG's physical address in SAM.gov is Rechenstrasse 37, 9014 St. Gallen, Switzerland.

Is Vifor (International) AG registered in SAM.gov?

Yes. Vifor (International) AG's SAM.gov registration is active through October 26, 2026.

Which contract vehicles does Vifor (International) AG hold?

Vifor (International) AG holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Vifor (International) AG's most recent federal award?

Vifor (International) AG's most recent federal contract award is Korsuva (difelikefalin) (36C25226N0475), from Veterans Integrated Service Network 12, on July 2, 2026.

On GovTribe

See Vifor (International) AG's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors